ESR1 and breast carcinoma: This prediction was validated in CCLE group of breast cancer cell lines, where both the expression levels of PD-L1 and corresponding ssGSEA scores of PD-L1 associated gene set were significantly negatively correlated to ESR1 expression levels (Figure 4I).